A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5733-5744

  Panwala, Chetan M ^a   Jones, Jon C ^a   Viney, Joanne L ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; IMMUNOREACTIVITY; INTESTINE EPITHELIUM; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; COLON; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENES, MDR; IMMUNOGLOBULINS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; P-GLYCOPROTEIN;

EID: 0032534043     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Mac-Donald, T. T. 1995. Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:445.
2. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K.-H. Meyer zum Büschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:448.
3. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3:171.
4. Kühn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
5. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274.
6. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
7. Holländer, G. A., S. J. Simpson, E. Mizoguchi, A. Nichogiannopoulou, J. She, J. C. Gutierrez-Ramos, A. K. Bhan, S. J. Burakoff, B. Wang, and C. Terhorst. 1995. Severe colitis in mice with aberrant thymic selection. Immunity 3:27.
8. Mizoguchi, A., E. Mizoguchi, C. Chiba, G. M. Spiekermann, S. Tonegawa, C. Nagler-Anderson, and A. K. Bhan. 1996. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J. Exp. Med. 183:847.
9. + T cells. J. Exp. Med. 178: 237.
10. Strober, W., and R. O. Ehrhardt. 1993. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203.
11. Elson, C. O., R. B. Sartor, G. S. Tennyson, and R. H. Riddell. 1995. Experimental models of inflammatory bowel disease. Gastroenterology 109:1344.
12. high T cells to SCID recipients. J. Immunol. 158:3464.
13. lo T cells. Res. Immunol. 145:357.
14. Dianda, L., A. M. Hanby, N. A. Wright, A. Sebesteny, A. C. Hayday, and M. J. Owen. 1997. T cell receptor-αβ-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150:91.
15. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, M. Zhou, J. L. Fernández-Sueiro, E. Balish, and R. E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359.
16. Videla, S., J. Vilaseca, F. Guarner, A. Salas, F. Treserra, E. Crespo, M. Antolin, and J. R. Malagelada. 1994. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 35:1090.
17. Macpherson, A., U. Y. Khoo, I. Forgacs, J. Philpott-Howard, and I. Bjarnason. 1996. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38:365.
18. Hermiston, M. L., and J. I. Gordon. 1995. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270:1203.
19. Bommhardt, U., J.-C. Cerottini, and H. R. MacDonald. 1994. Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function. Ear. J. Immunol. 24: 2974.
20. Drach, D., S. Zhao, J. Drach, R. Mahadevia, C. Gattringer, H. Huber, and M. Andreeff. 1992. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729.
21. Croop, J. M., M. Raymond, D. Haber, A. Devault, R. J. Arceci, P. Gros, and D. E. Housman. 1989. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol. 9:1346.
22. Buschman, E., R. J. Arceci, J. M. Croop, M. Che, I. M. Arias, D. E. Housman, and P. Gros. 1992. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J. Biol. Chem. 267: 18093.
23. Georges, E., G. Bradley, J. Gariepy, and V. Ling. 1990. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:152.
24. Thiebaut, F., T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. 1987. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84:7735.
25. Gottesman, M. M., and I. Pastan. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385.
26. Leveille-Webster, C. R., and I. M. Arias. 1995. The biology of the P-glycoproteins. J. Membr. Biol. 143:89.
27. Juliano, R. L., and V. Ling. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 455: 152.
28. Ueda, K., C. Cardarelli, M. M. Gottesman, and I. Pastan. 1987. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 84:3004.
29. Devault, A., and P. Gros. 1990. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10:1652.
30. Witkowski, J. M., S. P. Li, G. Gorgas, and R. A. Miller. 1994. Extrusion of the P glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2-driven IL-4 production. J. Immunol. 153:658.
31. Schinkel, A. H., E. Wagenaar, C. A. A. M. Mol, and L. van Deemter. 1996. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97:2517.
32. Schinkel, A. H., J. J. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491.
33. Schinkel, A. H., E. Wagenaar, L. van Deemter, C. A. A. M. Mol, and P. Borst. 1995. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96:1698.
34. Schinkel, A. H., U. Mayer, E. Wagenaar, C. A. A. M. Mol, L. van Deemter, J. J. M. Smit, M. A. van der Valk, A. C. Voordouw, H. Spits, O. van Tellingen, J. M. Zijlmans, W. E. Fibbe, and P. Borst. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94:4028.
35. + T cells in murine intestinal epithelium. Eur. J. Immunol. 20:1623.
36. Davies, M. D., and D. M. Parrrott. 1981. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut 22:481.
37. Brandwein, S. L., R. P. McCabe, Y. Cong, K. B. Waites, B. U. Ridwan, P. A. Dean, T. Ohkusa, E. H. Birkenmeier, J. P. Sundberg, and C. O. Elson. 1997. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159:44.
38. Maliszewski, C. R., P. J. Morrissey, W. C. Fanslow, T. A. Sato, C. Willis, and B. Davison. 1992. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell. Immunol. 143:434.
39. Foltz, C. J., J. G. Fox, R. Cahill, J. C. Murphy, L. Yan, B. Shames, and D. B. Schauer. 1998. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3:69.
40. Shomer, N. H., C. A. Dangler, M. D. Schrenzel, and J. G. Fox. 1997. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect. Immun. 65:4858.
41. Haines, D. C., P. L. Gorelick, J. K. Battles, K. M. Pike, R. J. Anderson, J. G. Fox. N. S. Taylor, Z. Shen, F. E. Dewhirst, M. R. Anver, and J. M. Ward. 1998. Inflammatory large bowel disease in immunodeficient rats naturally and experimentally infected with Helicobacter bilis. Vet. Pathol. 35:202.
42. Rudolph, U., M. J. Finegold, S. S. Rich, G. R. Harriman, Y. Srinivasan, P. Brabet, G. Boulay, A. Bradley, and L. Bimbaumer. 1995. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 10:143.
43. Taurog, J. D., S. D. Maika, W. A. Simmons, M. Breban, and R. E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168.
44. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5:1461.
45. Wen, L., S J. Roberts, J. L. Viney, F. S. Wong, C. Mallick, R. C. Findly, Q. Peng, J. E. Craft, M. J. Owen, and A. C. Hayday. 1994. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cells. Nature 369:654.
46. Elson, C. O., K. W. Beagley, A. T. Sharmanov, K. Fujihashi, H. Kiyono, G. S. Tennyson, Y. Cong, C. A. Black, B. W. Ridwan, and J. R. McGhee. 1996. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J. Immunol. 157:2174.
47. + αβ T cells in SCID mice with colitis. Eur. J. Immunol. 26:3074.
48. Sparreboom, A., J. van Asperen, U. Mayer, A. H. Schinkel, J. W. Smit, D. K. Meijer, P. Borst, W. J. Nooijen, J. H. Beijnen, and O. van Tellingen. 1997. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA 94:2031.
49. Higgins, C. F. 1995. Volume-activated chloride currents associated with the multidrug resistance P-glycoprotein. J. Physiol. 482:315.
50. Thévenod, F., J.-P. Hildebrandt, J. Striessnig, H. R. de Jonge, and I. Schulz. 1996. Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by a ∼80-kDa mdr1a gene product. J. Biol. Chem. 271:3300.
51. Valverde, M. A., M. Díaz, F. V. Sepúlveda, D. R. Gill, S. C. Hyde, and C. F. Higgins. 1992. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355:830.